Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Mohammad Fazel, Neda AlRawashdh, Ahmad Alamer, Clara Curiel-Lewandrowski & Ivo Abraham. (2021) Is there still a role for talimogene laherparepvec (T-VEC) in advanced melanoma? An indirect efficacy comparison of T-VEC plus ipilimumab combination therapy versus T-VEC alone as salvage therapy in unresectable metastatic melanoma. Expert Opinion on Biological Therapy 21:12, pages 1647-1653.
Read now
Read now
Articles from other publishers (27)
Sophia Z. Shalhout, David M. Miller, Kevin S. Emerick & Howard L. Kaufman. (2023) Therapy with oncolytic viruses: progress and challenges. Nature Reviews Clinical Oncology 20:3, pages 160-177.
Crossref
Crossref
E.H.A. Stahlie, A.C.J. van Akkooi & E. Plasmeijer. (2022) Dermoscopy as response evaluation tool for cutaneous malignant melanoma metastases treated with Talimogene Laherparepvec: a prospective feasibility study. Journal of the European Academy of Dermatology and Venereology 36:12, pages 2373-2378.
Crossref
Crossref
Annette Runge, Monika Petersson & Herbert Riechelmann. (2022) Onkolytische Virotherapie bei Kopf-Hals-Karzinomen. Laryngo-Rhino-Otologie 101:10, pages 787-796.
Crossref
Crossref
Zhongbing Qi, Xiangyu Long, Jiyan Liu & Ping Cheng. (2022) Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy. Frontiers in Cellular Neuroscience 16.
Crossref
Crossref
Emma H. A. Stahlie, Michael J. Carr, Jonathan S. Zager & Alexander C. J. van Akkooi. (2021) External Validation of a Dutch Predictive Nomogram for Complete Response to T-VEC in an Independent American Patient Cohort. Annals of Surgical Oncology 29:3, pages 1637-1644.
Crossref
Crossref
Michael J. Carr, James Sun, Danielle DePalo, Luke D. Rothermel, Yun Song, Richard J. Straker, Kristin Baecher, Raphael J. Louie, Emma H. A. Stahlie, G. Paul Wright, Syeda Mahrukh Hussnain Naqvi, Youngchul Kim, Amod A. Sarnaik, Giorgos C. Karakousis, Michael C. Lowe, Keith A. Delman, Alexander C. J. van Akkooi, David W. Ollila, Frances Collichio & Jonathan S. Zager. (2021) Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience. Annals of Surgical Oncology 29:2, pages 791-801.
Crossref
Crossref
Francisco Javier García Martínez. 2022. Textbook of Dermatologic Ultrasound. Textbook of Dermatologic Ultrasound
509
515
.
Jonathan Santos Apolonio, Vinícius Lima de Souza Gonçalves, Maria Luísa Cordeiro Santos, Marcel Silva Luz, João Victor Silva Souza, Samuel Luca Rocha Pinheiro, Wedja Rafaela de Souza, Matheus Sande Loureiro & Fabrício Freire de Melo. (2021) Oncolytic virus therapy in cancer: A current review. World Journal of Virology 10:5, pages 229-255.
Crossref
Crossref
Emma H. A. Stahlie, Viola Franke, Charlotte L. Zuur, Willem M. C. Klop, Bernies van der Hiel, Bart A. Van de Wiel, Michel W. J. M. Wouters, Yvonne M. Schrage, Winan J. van Houdt & Alexander C. J. van Akkooi. (2021) T-VEC for stage IIIB-IVM1a melanoma achieves high rates of complete and durable responses and is associated with tumor load: a clinical prediction model. Cancer Immunology, Immunotherapy 70:8, pages 2291-2300.
Crossref
Crossref
Lauren M. B. Burke, Hyeon Yu, Kaleigh Burke, Morgan Gwynn, Raphael J. Louie, David W. Ollila, Paula Landman RN & Frances Collichio. (2021) Ultrasound-guided Intralesional Injection of Talimogene laherparepvec (Imlygic) for Advanced Melanoma: Technical Note on a Preliminary Experience. CardioVascular and Interventional Radiology 44:5, pages 801-806.
Crossref
Crossref
Brad Rumancik & Lawrence Mark. (2021) Injectables in Head and Neck Cutaneous Melanoma Treatment. Otolaryngologic Clinics of North America 54:2, pages 425-438.
Crossref
Crossref
A.Y. Gavrilov, I.A. Sennikov, A.E. Kotenko, M.Y. Koval & S.N. Sharun. (2021) The role of immunogenic clinical death in the virotherapy of malignant neoplasms. Experimental and Clinical Medicine 90:1.
Crossref
Crossref
Marcin Zdzienicki, Piotr Rutkowski, Evalyn Mulder & Dirk J. Grunhagen. 2021. New Therapies in Advanced Cutaneous Malignancies. New Therapies in Advanced Cutaneous Malignancies
265
277
.
Yevhenii Trehub & Andrii Havrilov. 2021. Cancer Immunology. Cancer Immunology
509
541
.
Mark R. Middleton, Christoph Hoeller, Olivier Michielin, Caroline Robert, Caroline Caramella, Katarina Öhrling & Axel Hauschild. (2020) Intratumoural immunotherapies for unresectable and metastatic melanoma: current status and future perspectives. British Journal of Cancer 123:6, pages 885-897.
Crossref
Crossref
Karyn Haitz, Hasan Khosravi, Jennifer Y. Lin, Tyler Menge & Vinod E. Nambudiri. (2020) Review of talimogene laherparepvec: A first-in-class oncolytic viral treatment of advanced melanoma. Journal of the American Academy of Dermatology 83:1, pages 189-196.
Crossref
Crossref
Lizhi Li, Shixin Liu, Duoduo Han, Bin Tang & Jian Ma. (2020) Delivery and Biosafety of Oncolytic Virotherapy. Frontiers in Oncology 10.
Crossref
Crossref
Oliver Kepp, Aurelien Marabelle, Laurence Zitvogel & Guido Kroemer. (2019) Oncolysis without viruses — inducing systemic anticancer immune responses with local therapies. Nature Reviews Clinical Oncology 17:1, pages 49-64.
Crossref
Crossref
Ozan S. Kumru, Soraia Saleh-Birdjandi, Lorena R. Antunez, Eddy Sayeed, David Robinson, Sjoerd van den Worm, Geoffrey S. Diemer, Wilma Perez, Patrizia Caposio, Klaus Früh, Sangeeta B. Joshi & David B. Volkin. (2019) Stabilization and formulation of a recombinant Human Cytomegalovirus vector for use as a candidate HIV-1 vaccine. Vaccine 37:44, pages 6696-6706.
Crossref
Crossref
Vania Hom, Emoke Karonis, Tara Sigidi & Kristin Cawley. (2019) Development of a Nursing Policy for the Administration of an Oncolytic Virus in the Outpatient Setting. Seminars in Oncology Nursing 35:5, pages 150928.
Crossref
Crossref
Robert H.I. Andtbacka, Thomas Amatruda, John Nemunaitis, Jonathan S. Zager, John Walker, Jason A. Chesney, Kate Liu, Cheng-Pang Hsu, Cheryl A. Pickett & Janice M. Mehnert. (2019) Biodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanoma. EBioMedicine 47, pages 89-97.
Crossref
Crossref
Morgan L. Hennessy, Praveen K. Bommareddy, Genevieve Boland & Howard L. Kaufman. (2019) Oncolytic Immunotherapy. Surgical Oncology Clinics of North America 28:3, pages 419-430.
Crossref
Crossref
Ann Silk, Praveen K. Bommareddy & Howard L. Kaufman. 2018. Melanoma. Melanoma
1
17
.
Ann Silk, Praveen K. Bommareddy & Howard L. Kaufman. 2019. Melanoma. Melanoma
699
715
.
Jaqueline Ghosn, Alex Vicino, Olivier Michielin, George Coukos, Thierry Kuntzer & Michel Obeid. (2018) A severe case of neuro-Sjögren’s syndrome induced by pembrolizumab. Journal for ImmunoTherapy of Cancer 6:1.
Crossref
Crossref
Frances Collichio, Lauren Burke, Amber Proctor, Diana Wallack, Anthony Collichio, Patricia K. Long & David W. Ollila. (2018) Implementing a Program of Talimogene laherparepvec. Annals of Surgical Oncology 25:7, pages 1828-1835.
Crossref
Crossref
Helene Woyczesczyk & Karim Essani. 2018. Melanoma. Melanoma
515
524
.